Beyond pigmentation: toward a melasma vascular assessment index for precision assessment of melasma

Melasma has traditionally been regarded as a pigmentary disorder and assessed predominantly using pigmentation-based instruments, particularly the Melasma Area and Severity Index (MASI) and modified MASI (mMASI). However, advances in molecular biology, histopathology, dermoscopy, and non-invasive imaging have expanded its biological model to include vascular remodeling, inflammation, dermal alterations, photoaging, and skin barrier dysfunction. Vascular involvement is increasingly recognized as biologically relevant, clinically observable, and potentially therapeutically actionable, yet its assessment remains heterogeneous and lacks a standardized clinical framework. In this Perspective, we propose the Melasma Vascular Assessment Index (MVAI) as a complementary framework for characterizing the vascular phenotype of melasma. We provide a provisional definition and identify three candidate domains: vascular extent/distribution, intensity/prominence, and morphology/pattern. These domains require empirical refinement before MVAI can be operationalized as a scoring instrument. We further propose a seven-stage roadmap encompassing construct refinement, content validation, scoring development, measurement-property evaluation, responsiveness, incremental clinical utility, and external validation. Integration with dermoscopy, quantitative imaging, and artificial intelligence-assisted analysis may subsequently enhance assessment. If validated, MVAI could complement MASI or mMASI by enabling parallel characterization of pigmentary and vascular manifestations, distinguishing residual disease components, evaluating vascular-targeted interventions, and informing mechanism-based treatment selection. This approach may advance precision assessment alongside precision treatment in melasma.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-13
DOI
https://doi.org/10.3389/fmed.2026.1982475
Primary Topic
Dermatologic Treatments and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Beyond pigmentation: toward a melasma vascular assessment index for precision assessment of melasma

Krit Pongpirul, Pichit Suvanprakorn
1 links
Frontiers in Medicine
Dermatologic Treatments and Research
article

Beyond pigmentation: toward a melasma vascular assessment index for precision assessment of melasma

Krit Pongpirul, Pichit Suvanprakorn
article en

Abstract

Melasma has traditionally been regarded as a pigmentary disorder and assessed predominantly using pigmentation-based instruments, particularly the Melasma Area and Severity Index (MASI) and modified MASI (mMASI). However, advances in molecular biology, histopathology, dermoscopy, and non-invasive imaging have expanded its biological model to include vascular remodeling, inflammation, dermal alterations, photoaging, and skin barrier dysfunction. Vascular involvement is increasingly recognized as biologically relevant, clinically observable, and potentially therapeutically actionable, yet its assessment remains heterogeneous and lacks a standardized clinical framework. In this Perspective, we propose the Melasma Vascular Assessment Index (MVAI) as a complementary framework for characterizing the vascular phenotype of melasma. We provide a provisional definition and identify three candidate domains: vascular extent/distribution, intensity/prominence, and morphology/pattern. These domains require empirical refinement before MVAI can be operationalized as a scoring instrument. We further propose a seven-stage roadmap encompassing construct refinement, content validation, scoring development, measurement-property evaluation, responsiveness, incremental clinical utility, and external validation. Integration with dermoscopy, quantitative imaging, and artificial intelligence-assisted analysis may subsequently enhance assessment. If validated, MVAI could complement MASI or mMASI by enabling parallel characterization of pigmentary and vascular manifestations, distinguishing residual disease components, evaluating vascular-targeted interventions, and informing mechanism-based treatment selection. This approach may advance precision assessment alongside precision treatment in melasma.

Frontiers in MedicineVol. 13
Thai Red Cross Society (TH), University of Liverpool (GB), Chulalongkorn University (TH)
Good health and well-being
Dermatologic Treatments and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon